The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia: A randomized, double-blind, multicenter crossover trial

Annals of Internal Medicine

Volumn 135, Issue 3, 2001, Pages 165-174

  Eijkhout, H W ^a   Van der Meer, J W M ^a   Kallenberg, C G M ^a   Weening, R S ^a   Van Dissel, J T ^a   Sanders, L A M ^a   Strengers, P F W ^a   Nienhuis, H ^a   Schellekens, P Th A ^a  

^a Medical Department   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEVER; HOSPITAL ADMISSION; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MULTICENTER STUDY; NETHERLANDS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION;

EID: 0035822661     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-3-200108070-00008     Document Type: Article

References (21)

1. Infectious complications of the primary immunodeficiencies
2. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia
3. The primary immunodeficiencies
4. Immunoglobulin deficiency, syndromes and therapy
5. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia
6. X-linked agammaglobulinemia. A clinical and molecular analysis
7. Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications
8. Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia
9. Agammaglobulinemia
10. The gamma globulins. IV. Therapeutic uses of gamma globulin
11. Intravenous immune globulin therapy in hypogammaglobulinemia. A review
12. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia
13. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease
14. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease
15. Primary immunodeficiency diseases. Report of a WHO scientific group
16. General guidelines for the clinical evaluation of anti-infective drug products
17. Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment
18. Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency
19. Prophylactic effect of self-administered pump-driven subcutaneous IgG infusion in patients with antibody deficiency: A triple-blind cross-over study comparing P-IgG levels of 3 g L - 1 versus 6 g L - 1
20. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases
21. Nasal administration of IgA to individuals with hypogammaglobulinemia